Publications

Meissner WG, Remy P, Giordana C, Maltête D, Derkinderen P, Houéto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrière N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O; LIXIPARK Study Group. Trial of Lixisenatide in Early Parkinson’s Disease. 2024. The New England Journal of Medicine. 390. 1176-1185.

Ylenia D'elia, Tim Whitfield, Marco Schlosser, Antoine Lutz, Thorsten Barnhofer, Gaël Chételat, Natalie L. Marchant, Julie Gonneaud, Olga Klimecki, The Medit-Ageing group. Impact of mindfulness-based and health self-management interventions on mindfulness, self-compassion, and physical activity in older adults with subjective cognitive decline: A secondary analysis of the SCD-Well randomized controlled trial. 2024. Alzheimer's & dementia (Amsterdam, Netherlands). 16. e12558.

Edward Man-Lik Choi, Boris Lacarra, Muhammed O Afolabi, Boni Maxime Ale, Frank Baiden, Christine Bétard, Julie Foster, Benjamin Hamzé, Christine Schwimmer, Daniela Manno, Eric D'Ortenzio, David Ishola, Cheick Mohamed Keita, Babajide Keshinro, Yusupha Njie, Wim van Dijck, Auguste Gaddah, Dickson Anumendem, Brett Lowe, Renaud Vatrinet, Bolarinde Joseph Lawal, Godfrey T Otieno, Mohamed Samai, Gibrilla Fadlu Deen, Ibrahim Bob Swaray, Abu Bakarr Kamara, Michael Morlai Kamara, Mame Aminata Diagne, Dickens Kowuor, Chelsea McLean, Bailah Leigh, Abdoul Habib Beavogui, Maarten Leyssen, Kerstin Luhn, Cynthia Robinson, Macaya Douoguih, Brian Greenwood, Rodolphe Thiébaut, Deborah Watson-Jones ; EBOVAC-3/EBL2005 Study Team. Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone. 2023. The Lancet Global Health. 11. e1743-e1752.

Ciani O, Manyara AM, Davies P, Stewart D, Weir CJ, Young AE, Blazeby J, Butcher NJ, Bujkiewicz S, Chan AW, Dawoud D, Offringa M, Ouwens M, Hróbjartssson A, Amstutz A, Bertolaccini L, Bruno VD, Devane D, Faria CDCM, Gilbert PB, Harris R, Lassere M, Marinelli L, Markham S, Powers JH, Rezaei Y, Richert L, Schwendicke F, Tereshchenko LG, Thoma A, Turan A, Worrall A, Christensen R, Collins GS, Ross JS, Taylor RS. A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials. 2023. eClinicalMedicine. 65. 102283.

Andrew W Lee, Ken Liu, Edouard Lhomme, Julie Blie, John McCullough, Matthew T Onorato, Laurie Connor, Jakub K Simon, Sheri Dubey, Susan VanRheenen, Jonathan Deutsch, Abigail Owens, Amy Morgan, Carolee Welebob, Donna Hyatt, Sunita Nair, Benjamin Hamzé, Oumar Guindo, Samba O Sow, Abdoul H Beavogui, Bailah Leigh, Mohamed Samai, Pauline Akoo, Alimamy Serry-Bangura, Suzanne Fleck, Fatou Secka, Brett Lowe, Deborah Watson-Jones, Céline Roy, Lisa E Hensley, Mark Kieh, Beth-Ann G Coller, the PREVAC Study Team. Immunogenicity and vaccine shedding after 1 or 2 doses of rVZVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®): Results from a phase 2, randomized, placebo-controlled trial in children and adults. 2023. Clinical Infectious Diseases. 78. 870-879.

PREVAC Study Team; Mark Kieh, Laura Richert, Abdoul H Beavogui, Birgit Grund, Bailah Leigh, Eric D'Ortenzio, Seydou Doumbia, Edouard Lhomme, Samba Sow, Renaud Vatrinet, Céline Roy, Stephen B Kennedy, Sylvain Faye, Shelley Lees, Niouma P Millimouno, Alseny M Camara, Mohamed Samai, Gibrilla F Deen, Moussa Doumbia, Hélène Espérou, Jerome Pierson, Deborah Watson-Jones, Alpha Diallo, Deborah Wentworth, Chelsea McLean, Jakub Simon, Aurélie Wiedemann, Bonnie Dighero-Kemp, Lisa Hensley, H Clifford Lane, Yves Levy, Peter Piot, Brian Greenwood, Geneviève Chêne, James Neaton, Yazdan Yazdanpanah. Randomized Trial of Vaccines for Zaire Ebola Virus Disease. 2022. The New England Journal of Medicine. 387. 2411-2424.

Chételat G, Lutz A, Klimecki O, Frison E, Asselineau J, Schlosser M, Arenaza-Urquijo EM, Mézenge F, Kuhn E, Moulinet I, Touron E, Dautricourt S, André C, Palix C, Ourry V, Felisatti F, Gonneaud J, Landeau B, Rauchs G, Chocat A, Quillard A, Devouge EF, Vuilleumier P, de La Sayette V, Vivien D, Collette F, Poisnel G, Marchant N ; the Medit-Ageing Research Group. Effect of an 18-Month Meditation Training on Regional Brain Volume and Perfusion in Older Adults: The Age-Well Randomized Clinical Trial. 2022. JAMA Neurology. 79. 1165-1174.

Tim Whitfield, Harriet Demnitz-King, Marco Schlosser, Thorsten Barnhofer, Eric Frison, Nina Coll-Padros, Sophie Dautricourt, Florence Requier, Marion Delarue, Julie Gonneaud, Olga M. Klimecki, Antoine Lutz, Léo Paly, Eric Salmon, Ann-Katrin Schild, Zuzana Walker, Frank Jessen, Gaël Chételat, Fabienne Collette, Miranka Wirth, Natalie L. Marchant & The Medit-Ageing Research Group. Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial. 2022. Alzheimers Research Therapy. 14. 1010-1016.

Alexandre Duvignaud, Edouard Lhomme, Racha Onaisi, Rémi Sitta, Ambre Gelley, Julie Chastang, Lionel Piroth, Christine Binquet, Julie Dupouy, Alain Makinson , Benjamin Lefèvre, Jean-Marc Naccache, Caroline Roussillon, Roland Landman, Cédrick Wallet, Sophie Karcher, Valérie Journot, Duc Nguyen, Thierry Pistone, Stéphane Bouchet, Marie-Edith Lafon, Mathieu Molimard, Rodolphe Thiébaut, Xavier de Lamballerie, Jean-Philippe Joseph, Laura Richert, Olivier Saint-Lary, Sarah Djabarouti, Linda Wittkop, Xavier Anglaret, Denis Malvy ; Coverage Study Group. Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE). 2022. Clinical Microbiology and Infection. 28. 00108-2.